Recent developments in oncology continue to present hope for patients. Researchers are actively exploring novel approaches, including immunotherapy , targeted therapies , and personalized approaches. A major research published this week demonstrates the potential of a cancer center journal club new drug in managing late-stage NSCLC. Furthermore, on